Resultados de la búsqueda 261-270 of 4163 for Relapse
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL ... relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have ...
... relapse. Intravenous Ketamine for Treatment-Resistant Depression (G2K). Rochester, Minn. The purpose of this study is to to evaluate the relationships ...
This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT ( ...
Infórmate sobre la salud del adulto, incluyendo salud física y mental y problemas en las relaciones y el trabajo.
KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...
Additionally, no studies to date have investigated this during intralesional tumor resections. NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND.
... relapsed NSCLC. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn ...
A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?